Full name
FIBIOMED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
FIBIOMED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. GŁĘBOKA 39, 20-612 LUBLIN
TAX ID7123404394
Rate company:
FIBIOMED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID7123404394
KRS0000850276
Share capital35,000.00 zł
address
UL. GŁĘBOKA 39, 20-612 LUBLIN
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
7123404394
REGON
386526444
KRS
0000850276
Legal form
limited liability company
Register Address
UL. GŁĘBOKA 39, 20-612 LUBLIN
Date of registration in KRS
2020-07-14
Date of commencement of economic activity
2020-07-14
Act signature
LU.VI NS-REJ.KRS/17179/24/475
Pkd codes
72.11.Z - Research and experimental development on biotechnology
10 - Manufacture of food products
10.89.Z - Manufacture of other food products not elsewhere classified
20 - Manufacture of chemicals and chemical products
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
26 - Manufacture of computer, electronic and optical products
70 - Activities of head offices; management consultancy activities
72 - Scientific research and development
77 - Rental and leasing activities
82 - Office administrative, office support and other business support activities
Payer VAT status
Active
Vat list bank account(s)
PL07 1050 1953 1000 0090 8109 2612 
PL74 1050 1953 1000 0090 8109 0921 PL82 1050 1953 1000 0090 8109 2620 PL96 1050 1953 1000 0090 8109 0913 Show more bank accounts from VAT list (1)
EU grants
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | -0,4 | -0,7 | -1,1 | -62,8 |
EBITDA | -0,4 | -0,7 | -1,1 | -58,4 |
Short time liabilities | 0,2 | 0,2 | 1,5 | 819,9 |
Equity capital | 1,1 | 0,4 | -0,7 | -253,7 |
Operating profit (EBIT) | -0,4 | -0,7 | -1,1 | -59,2 |
Assets | 2,5 | 0,6 | 0,9 | 35,4 |
Net profit (loss) | -0,4 | -0,7 | -1,1 | -62,3 |
Cash | 2,3 | 0,2 | 0 | -76,2 |
Liabilities and provisions for liabilities | 1,3 | 0,2 | 1,5 | 669,8 |
Net income from sale | 0,2 | 0 | 0 | -0,5 |
Working assets | 2,4 | 0,6 | 0,8 | 32 |
Depreciation | 0 | 0 | 0 | 531,2 |
% | % | % | p.p. | |
Profitability of capital | -33,8 | -156,3 | 165,1 | 321,4 |
Equity capital to total assets | 45,9 | 68,7 | -78 | -146,7 |
Gross profit margin | -247,9 | -28 675,5 | -46 935,5 | -18 260 |
EBITDA Margin | -246,7 | -28 641 | -45 616,3 | -16 975,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 384 | 25 431 | 235 220 | 209 789 |
Current financial liquidity indicator | 1.8463362455368042 | 3.7620961666107178 | 0.5397513508796692 | -3,3 |
Net dept to EBITDA | 6.041126728057861 | 0.2657943665981293 | -1.290358066558838 | -1,6 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Activity report
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdfShow more (1)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
Bartosz Wasąg
Gdańsk
BIOCELTIX SPÓŁKA AKCYJNA
WROCŁAW